SCHEMBL20530596

SCHEMBL20530596

C#CCOc1ccc2ccc(N)cc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 11/20 0.51
MAOA P21397 8/20 0.51
ACHE P22303 1/20 0.51
CA12 O43570 4/20 0.51
CA4 P22748 4/20 0.51
CA9 Q16790 4/20 0.51
CA1 P00915 2/20 0.49
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 2/20 0.44
HSD17B10 Q99714 2/20 0.44
GSTP1 P09211 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
ALOX15 P16050 1/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
HBB P68871 1/20 0.42
HIF1A Q16665 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
AGXT P21549 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20530611 0.96 MAOB (0.54) MAOBMAOAACHECA12CA4
SCHEMBL29646218 0.89 CA12 (0.60) MAOBMAOAACHECA12CA4
SCHEMBL9150649 0.89 CA12 (0.60) MAOBMAOAACHECA12CA4
SCHEMBL9061932 0.85 CA12 (0.64) MAOBMAOAACHECA12CA4
SCHEMBL9043883 0.82 CA12 (0.57) MAOBMAOAACHECA12CA4
SCHEMBL9293936 0.80 CA12 (0.55) MAOBMAOAACHECA12CA4
SCHEMBL20530609 0.79 CA12 (0.51) MAOBMAOAACHECA12CA4
SCHEMBL126400 0.79 CA12 (0.58) MAOBMAOAACHECA12CA4
SCHEMBL4670561 0.79 ALDH1A1 (0.42) MAOBMAOAACHECA12CA4
Hydrochloric Acid SCHEMBL19742209 0.77 CA12 (0.56) MAOBMAOAACHECA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11117873-B2 Oxazine compound, composition, and cured product DIC CORPORATION (JP) 2021-09-14 US disclosed
US-11028059-B2 Oxazine compound, composition and cured product DIC CORPORATION (JP) 2021-06-08 US disclosed
CN-108368217-B Oxazine compound, composition and cured product DIC株式会社 2021-05-07 CN disclosed
CN-108368216-B Oxazine compound, composition and cured product DIC株式会社 2020-09-18 CN disclosed
US-20180362480-A1 OXAZINE COMPOUND, COMPOSITION, AND CURED PRODUCT DIC CORPORATION (JP) 2018-12-20 US disclosed
US-20180362477-A1 OXAZINE COMPOUND, COMPOSITION AND CURED PRODUCT DIC CORPORATION (JP) 2018-12-20 US disclosed
EP-3388461-A1 OXAZINE COMPOUND, COMPOSITION, AND CURED PRODUCT DIC Corporation (JP) 2018-10-17 EP disclosed
EP-3388459-A1 OXAZINE COMPOUND, COMPOSITION AND CURED PRODUCT DIC Corporation (JP) 2018-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11028059-B2 Oxazine compound, composition and cured product KDM5A, WDR5, RNF5 MAOB 1747/4885MAOA 1166/4885ACHE 1217/4885
US-20180362480-A1 OXAZINE COMPOUND, COMPOSITION, AND CURED PRODUCT KDM5A, WDR5, SMC4 MAOB 1509/4885MAOA 894/4885ACHE 856/4885
US-11117873-B2 Oxazine compound, composition, and cured product KDM5A, WDR5, SMC4 MAOB 1509/4885MAOA 894/4885ACHE 856/4885
US-20180362477-A1 OXAZINE COMPOUND, COMPOSITION AND CURED PRODUCT KDM5A, WDR5, RNF5 MAOB 1747/4885MAOA 1166/4885ACHE 1217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.